MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 100 filers reported holding MYOVANT SCIENCES LTD in Q2 2020. The put-call ratio across all filers is 1.56 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $142,000 | -49.8% | 10,659 | -41.3% | 0.01% | -62.1% |
Q4 2021 | $283,000 | -22.0% | 18,147 | +12.2% | 0.03% | -9.4% |
Q3 2021 | $363,000 | -17.9% | 16,168 | -16.7% | 0.03% | -25.6% |
Q2 2021 | $442,000 | +25.9% | 19,405 | +13.8% | 0.04% | +72.0% |
Q1 2021 | $351,000 | -41.9% | 17,045 | -41.8% | 0.02% | -64.3% |
Q2 2020 | $604,000 | +429.8% | 29,308 | +133.6% | 0.07% | +900.0% |
Q2 2019 | $114,000 | – | 12,544 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
Matisse Capital | 32,750 | $508,000 | 0.36% |
VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |